Feline pheochromocytoma is a rare condition that can cause high blood pressure and heart problems due to hormone secretion. With proper management and treatment, your cat’s quality of life can be improved.





| Item | Key Points |
|---|---|
| Condition | Adrenal medullary tumor causing excess catecholamine secretion |
| Symptoms | Hypertension, weakness, fainting, respiratory distress, vision decline |
| Diagnosis | Blood pressure measurement, hormone testing, ultrasound/CT imaging |
| Treatment | Adrenalectomy after blood pressure stabilization, or medical management |
| Caution | Essential to be wary of unverified supplements and products claiming a cure |
This is not a table recommending specific products or clinics, but a reference to consult when talking with your veterinarian. Treatment and testing decisions must always be made together with a veterinarian through an examination.
Warning: Serious Side Effects Possible with Overdose
Feline pheochromocytoma requires management with medications prescribed by a veterinarian, and you should never adjust the dosage on your own. In particular, excessive use of blood pressure-lowering drugs can cause blood pressure to drop too low. This risk is even greater for cats with pre-existing heart conditions. Always consult your veterinarian before starting or changing any medication.


A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.
Share
[1] Rassnick KM, Williams LE, Kristal O et al. (2008) Lomustine for treatment of mast cell tumors in cats: 38 cases (1999-2005). Journal of the American Veterinary Medical Association 232, 1200-1205.
[2] The Cat, Clinical Medicine and Management, 2nd Edition. (2010) Blackwell Publishing.
[3] Veterinary Surgical Oncology, 2nd Ed. (2012) Wiley-Blackwell.